GUILLERMO MARIA
LOPEZ VIVANCO
Investigador/a en el periodo 2011-2020
Hospital Miguel Servet
Zaragoza, EspañaPublicaciones en colaboración con investigadoras/es de Hospital Miguel Servet (3)
2016
-
Treatment patterns of adjuvant interferon-α2b for high-risk melanoma: A retrospective study of the Grupo Español Multidisciplinar de Melanoma - Prima study
Melanoma Research, Vol. 26, Núm. 3, pp. 278-283
2012
-
Cardiac safety of adjuvant pegylated liposomal doxorubicin with concurrent trastuzumab: A randomized phase II trial
Annals of Oncology, Vol. 23, Núm. 7, pp. 1780-1788
-
Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): A multicentre, open-label, randomised phase 3 trial
The Lancet Oncology, Vol. 13, Núm. 3, pp. 239-246